Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhantomX is a medical technology company specializing in the development of patient-specific phantoms and AI-driven quality assurance solutions for medical imaging and radiation therapy. The company utilizes advanced 3D printing technology to create high-fidelity anatomical models that accurately mimic the physical properties of human tissue. These phantoms are used by clinicians to calibrate diagnostic equipment and verify radiation doses, ensuring high precision in oncology treatments. Their AI-powered platform automates the quality assurance process, reducing the time and complexity involved in medical imaging workflows. By bridging the gap between virtual planning and physical execution, PhantomX provides a 'digital twin' approach to personalized medicine. The company's products are designed to improve patient safety and treatment outcomes in complex clinical environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PhantomX.